tenk.fyi

HALOZYME THERAPEUTICS, INC.

HALONasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.4B

37.6% YoY

Net Income

$316.9M

28.6% YoY

EPS

$2.56

25.4% YoY

Cash

$133.8M

15.5% YoY

FY 2025 · As of 2025-12-31